Richard William Scalzo, SVP, Head of Finance & Administration at Dyne Therapeutics, Inc. (DYN), sold 917 shares at $11.83 ($11K) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Scheduled sale ($11k) by SVP, Head of Finance & Administration under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DYN | SELL | 2025-03-13 | $15K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |
| DYN | SELL | 2024-12-11 | $41K | — | Filing → |